about
Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisClinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signalingIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsTetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cellsExpression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cellsMolecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoiresInhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatasesBovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status.NK cells and apoptosis.Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligaseFunctional CD32 molecules on human NK cells.Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog.Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltratesExpression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivoOn guard--activating NK cell receptors.Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy.Human natural killer cell receptors and signal transduction.Ontogeny and expansion of human natural killer cells: clinical implications.Biology of natural killer cells in cancer and infection.The immunomodulating roles of glycoproteins in epithelial ovarian cancer.Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.Ageing is associated with a decline in peripheral blood CD56bright NK cells.KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretionA subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immatureTim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Pathological role of fractalkine/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions.The mother-child union: the case of missing-self and protection of the fetusReciprocal age related change in natural killer cell receptors for MHC class I.Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function.What goes up must come down: the emerging spectrum of inhibitory receptorsOn the cell biology of pit cells, the liver-specific NK cells.Signaling for synergistic activation of natural killer cells.Activation, coactivation, and costimulation of resting human natural killer cells
P2860
Q24645351-635E9896-B214-4642-A89E-18B77F81C7D8Q24646989-B2146D16-6E0F-414A-BF0C-AC5EE50BFF4EQ24647094-3B1838E3-1999-42D5-99AF-65DA490CE447Q24649116-3C148235-2297-40DE-9CC4-3E3A422DA03CQ24671834-F8AD43E1-EDF5-47A0-9352-B0BDC6258214Q24676756-D6D0BE01-6CC2-4FE5-9606-7FBDD050F09FQ24793218-7BAA682C-B73F-4A77-BD1E-D98672ADA552Q28137748-C80EBB9F-8BF3-4614-9D2F-46422AB0F014Q28138946-D122FC9A-40A0-4280-BADE-D5630B6FB4B3Q28263470-E07A3AF6-4AF1-4EBA-8AB1-569D23048B6DQ33241391-58065C23-70FE-492F-BBD6-23C18701B58DQ33547794-567A7835-F3F9-427C-A834-6F94FD385C2BQ33745662-80CC5C05-A21A-48AD-8997-3E6019EBC317Q33747251-DA30C1DB-AFE4-42BA-8937-1989F250C193Q33782034-4B55236C-8547-4C7E-BF61-A3109153C09FQ33783800-366A2982-37FE-4775-86C2-FCF669B6D68DQ33804205-296FF125-ABFC-4FCE-B934-B2C6A453A065Q33835521-602C833F-D398-42E5-88CE-A84A719A7CC2Q33944680-D78908F6-5BC9-405F-9E28-68BE1668FEE4Q34117069-7A2BB94F-D359-4077-9C21-B7787C5DC30FQ34537157-E4C428B6-ABE4-4E3A-9F1F-EBCE375A773CQ34552143-4BE3BDA9-6022-40B5-BE62-8B0E047503ADQ34552167-21922F2C-3B68-4BCB-876C-834DFDBE9174Q34651546-E8B7890B-E533-4D51-B47A-784F355E1900Q35077893-8084F25A-7737-40B5-AFED-03B27A8771B3Q35137164-7FAEED0E-2E58-48C7-885A-D788ECBD9664Q35225681-F79AB4A4-6DA8-4871-A9B4-C486A677BB69Q35848151-03AB568B-1C31-4A50-8516-25C6F45480C9Q35848493-808440EF-BC0E-4BB3-AD79-11F9F614DB1EQ35900982-E0A22A81-436F-4181-901E-A3A5BC0E695EQ35909663-B43D0461-C47E-4256-8873-7F6E9A8B020DQ35927383-5451DB5F-E804-4C24-A2BC-0435CF9C30BEQ36009126-864AA7F6-2058-4519-83A0-AE13130FA1D3Q36088741-280FE611-D1BF-4688-AA43-614B6435A62EQ36301388-E226FE35-150E-4BFA-BF03-C0E50E139B76Q36370106-E7534669-1FA1-4853-9378-11C01E6D365CQ36380962-126AB3D5-841C-4222-8CE0-842C9C918960Q36492081-37151FEB-E8AA-4EFD-AA1F-3EF146079825Q36592767-80B15D37-2BDC-4918-8341-832AD2A06CFCQ36652166-7DE4C608-A12D-4E2E-9D7D-5F7FCA0FE29B
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Arousal and inhibition of human NK cells.
@en
type
label
Arousal and inhibition of human NK cells.
@en
prefLabel
Arousal and inhibition of human NK cells.
@en
P2093
P2860
P1476
Arousal and inhibition of human NK cells.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1997.TB00947.X
P577
1997-02-01T00:00:00Z